Error message

The page you requested does not exist. For your convenience, a search was performed using the query Infectious Diseases Vaccines.

Page not found

Search results

  1. Sell Your Science- Best Practices for Developing an Effective Non-Confidential Pitch Deck

    diseases and Vaccines; and neurobiology. Prior to joining the Johnson & Johnson Family of Companies, ... in infectious disease, oncology, immunotherapy, and monogenetic disorders. His experience includes pre-clinical ... & Johnson Innovation, Boston. He focuses primarily on cardiovascular & metabolic; infectious ...

  2. [San Antonio TX session] Sell Your Science: Best Practices for Developing an Effective Non-Confidential Pitch Deck

    on cardiovascular & metabolic; infectious diseases and Vaccines; and neurobiology. Prior to joining the Johnson ... through Phase II programs in infectious disease, oncology, immunotherapy, and monogenetic disorders. His ... across a number of successful early-stage investments in the rare disease space. He was member of the BOD ...

  3. Sell Your Science- Best Practices for Developing an Effective Non-Confidential Pitch Deck

    on cardiovascular & metabolic; infectious diseases and Vaccines; and neurobiology. Prior to joining the Johnson ... through Phase II programs in infectious disease, oncology, immunotherapy, and monogenetic disorders. His ... across a number of successful early-stage investments in the rare disease space. He was member of the BOD ...

  4. [Austin TX session] Sell Your Science: Best Practices for Developing an Effective Non-Confidential Pitch Deck

    on cardiovascular & metabolic; infectious diseases and Vaccines; and neurobiology. Prior to joining the Johnson ... through Phase II programs in infectious disease, oncology, immunotherapy, and monogenetic disorders. His ... across a number of successful early-stage investments in the rare disease space. He was member of the BOD ...

  5. [San Antonio TX session] Sell Your Science: Best Practices for Developing an Effective Non-Confidential Pitch Deck

    on cardiovascular & metabolic; infectious diseases and Vaccines; and neurobiology. Prior to joining the Johnson ... through Phase II programs in infectious disease, oncology, immunotherapy, and monogenetic disorders. His ... across a number of successful early-stage investments in the rare disease space. He was member of the BOD ...

  6. [NYC session] Sell Your Science: Best Practices for Developing an Effective Non-Confidential Pitch Deck

    on cardiovascular & metabolic; infectious diseases and Vaccines; and neurobiology. Prior to joining the Johnson ... through Phase II programs in infectious disease, oncology, immunotherapy, and monogenetic disorders. His ... across a number of successful early-stage investments in the rare disease space. He was member of the BOD ...

  7. Peptide Logic

    infectious diseases, and oncology.   JLABS @ San Diego Oncology 0 Monday, October 2, 2017 ...

  8. Spotlight on JLABS- Austin, Texas

    focused primarily on cardiovascular & metabolic; infectious diseases and Vaccines; and neurobiology. ... has worked on multiple discovery through Phase II programs in infectious disease, oncology, ... diligence, and deal processes across a number of successful early-stage investments in the rare disease ...

  9. Spotlight on JLABS- Austin, Texas

    focused primarily on cardiovascular & metabolic; infectious diseases and Vaccines; and neurobiology. ... has worked on multiple discovery through Phase II programs in infectious disease, oncology, ... diligence, and deal processes across a number of successful early-stage investments in the rare disease ...

  10. Spotlight on JLABS- Austin, Texas

    focused primarily on cardiovascular & metabolic; infectious diseases and Vaccines; and neurobiology. ... has worked on multiple discovery through Phase II programs in infectious disease, oncology, ... diligence, and deal processes across a number of successful early-stage investments in the rare disease ...

Pages

Share